This inventor holds 4 USPTO granted patents. Top assignee: Dainippon Pharmaceutical Company, Limited. Active years: 1976-1979.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Ibaraki, JA (1976 - 1978)
- Ibaraki, JP (1979)
Company Filing History:
Years Active: 1976-1979
Title: Kagayaki Natsuka: Innovator in Pharmaceutical Chemistry
Introduction
Kagayaki Natsuka is a prominent inventor based in Ibaraki, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of piperazine derivatives. With a total of 4 patents to his name, Natsuka's work has the potential to impact various therapeutic areas.
Latest Patents
Natsuka's latest patents include innovative compounds such as 1-Substituted-4-(1,2-diphenylethyl)piperazine derivatives. These compounds feature specific structural formulas where X can be 2- or 3-hydroxy, 2-methoxy, 3-methyl, or 3-alkoxy with varying carbon chain lengths. The R group in these derivatives can include various substituents such as allyl, cyclohexyl, or phenyl groups. These compounds are not only novel but also have applications in analgesic or antitussive compositions, showcasing their therapeutic potential.
Career Highlights
Kagayaki Natsuka is associated with Dainippon Pharmaceutical Company, Limited, where he continues to innovate in the pharmaceutical sector. His work focuses on creating effective medicinal compounds that can address various health issues. His dedication to research and development has positioned him as a key figure in his field.
Collaborations
Natsuka has collaborated with notable colleagues such as Haruki Nishimura and Hitoshi Uno. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to the development of groundbreaking pharmaceutical solutions.
Conclusion
Kagayaki Natsuka's contributions to pharmaceutical chemistry through his innovative piperazine derivatives highlight his role as a significant inventor in the industry. His work not only advances scientific knowledge but also has the potential to improve patient care through new therapeutic options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
